1. Home
  2. PSO vs RGC Comparison

PSO vs RGC Comparison

Compare PSO & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSO
  • RGC
  • Stock Information
  • Founded
  • PSO 1844
  • RGC 2014
  • Country
  • PSO United Kingdom
  • RGC Hong Kong
  • Employees
  • PSO N/A
  • RGC N/A
  • Industry
  • PSO Books
  • RGC Medicinal Chemicals and Botanical Products
  • Sector
  • PSO Consumer Discretionary
  • RGC Health Care
  • Exchange
  • PSO Nasdaq
  • RGC Nasdaq
  • Market Cap
  • PSO 9.5B
  • RGC 8.4B
  • IPO Year
  • PSO 2000
  • RGC 2021
  • Fundamental
  • Price
  • PSO $13.13
  • RGC $13.39
  • Analyst Decision
  • PSO
  • RGC
  • Analyst Count
  • PSO 0
  • RGC 0
  • Target Price
  • PSO N/A
  • RGC N/A
  • AVG Volume (30 Days)
  • PSO 747.8K
  • RGC 146.9K
  • Earning Date
  • PSO 01-01-0001
  • RGC 10-24-2025
  • Dividend Yield
  • PSO 2.48%
  • RGC N/A
  • EPS Growth
  • PSO 31.65
  • RGC N/A
  • EPS
  • PSO 0.90
  • RGC N/A
  • Revenue
  • PSO $4,822,578,436.00
  • RGC N/A
  • Revenue This Year
  • PSO $2.17
  • RGC N/A
  • Revenue Next Year
  • PSO $5.10
  • RGC N/A
  • P/E Ratio
  • PSO $14.67
  • RGC N/A
  • Revenue Growth
  • PSO N/A
  • RGC N/A
  • 52 Week Low
  • PSO $13.07
  • RGC $0.09
  • 52 Week High
  • PSO $17.90
  • RGC $83.60
  • Technical
  • Relative Strength Index (RSI)
  • PSO 26.69
  • RGC 37.11
  • Support Level
  • PSO $13.63
  • RGC $12.60
  • Resistance Level
  • PSO $13.82
  • RGC $17.45
  • Average True Range (ATR)
  • PSO 0.16
  • RGC 1.15
  • MACD
  • PSO -0.16
  • RGC -0.39
  • Stochastic Oscillator
  • PSO 2.76
  • RGC 14.90

About PSO Pearson Plc

Pearson PLC listed in the U.K., is an educational provider. The company has been divesting non-core businesses such as the Financial Times, The Economist, and publishing house Penguin, and is now focused on being an educational resource and testing provider. While Pearson's primary activity centers on higher education, the firm also operates in providing clinical assessments, professional certification, and testing.

About RGC Regencell Bioscience Holdings Limited

Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.

Share on Social Networks: